Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight
NCT04306315
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
385
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis Vulgaris
Interventions
BIOLOGICAL:
Brodalumab
Sponsor
LEO Pharma